PRI's Focus on Health Care

View this email in your browser ([link removed])
Biden = Bernie, Obama admits. Just look at their policies
Featured on Fox News | Sally C. Pipes
August 31, 2020

Biden, equally famously, has rejected “Medicare-for-all.” He’s calling for a new public health insurance option to be sold alongside private insurance plans in ObamaCare’s exchanges. This is a Medicare buy-in by another name, as the public option will essentially dictate reimbursement rates to providers, just as Medicare does.
Read more. . . ([link removed])

The FDA’s Defenses Against Political Pressure Are Beginning to Crumble.
Human Events | Henry Miller, M.S., M.D.
August 28, 2020

It was no secret that there would be intense pressure on the FDA from a White House desperate for good news to provide an “October Surprise” in the form of a vaccine approval before the November 3rd election, even if that approval was premature. Well, it seems UPS and other delivery partners are reportedly planning to perform test runs in September, in preparation for actually beginning to ship a coronavirus vaccine by November 1st.
Read more. . . ([link removed])

A Look At The Democrats’ Not-So-Moderate Healthcare Platform
Forbes | Sally C. Pipes
August 28, 2020

Health care would appear to be the exception to that spirit of unity. More than 700 delegates to the Democratic National Convention said beforehand they’d oppose the party platform if it didn’t include a call for Medicare for All. Progressive firebrands like California Rep. Ro Khanna and Michigan Rep. Rashida Tlaib made a big show of publicizing their “no” votes on social media.
Read more. . . ([link removed])

Discipline, Determination, and Data Will Get Us Through the Pandemic
American Greatness | Henry Miller, M.S., M.D. and Andrew Fillat
August 28, 2020

As we battle the SARS-CoV-2 virus, and the illness it causes, COVID-19, the “fog of war” continues on both the medical and epidemiological fronts. On the public health side, different studies, especially those that involve modeling, seem to reach conflicting, or at least ambiguous, conclusions. And politicians and pundits have jumped in to make the fog denser, with many policy prescriptions contaminated by misinformation, ideological spin, and partisan politics.
Read more. . . ([link removed])

[link removed]
Watch the Latest "Escape the Drug Pricing Maze Video" ([link removed])
Making Biosimilars & Gene Therapies Affordable & Accessible: 3 Keys to Reform Drug Pricing System

As they approach the end of the Drug Pricing Maze, the Professor and Pete explore reforms to fix a broken system and encourage the use of cheaper biosimilars that can help patients and the health care system save big. They also learn what can be done to make very expensive gene therapies that provide a lot of value for patients more affordable and accessible.

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.